• 1
    Soykan I, Sivri B, Sarosiek I, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998; 43: 2398404.
  • 2
    Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 258991.
  • 3
    Hasler WL. Gastroparesis: symptoms, evaluation, and treatment. Gastroenterol Clin North Am 2007; 36: 61947.
  • 4
    Kong M-F, Horowitz M, Jones KL et al. Natural history of diabetic gastroparesis. Diabetes Care 1998; 22: 5037.
  • 5
    Revicki DA, Rentz AM, Dubois D et al. Developement and validation of a patient-assessed gastroparesis symptoms severity measure: the Gastroparesis Cardinal Symptoms Index. Aliment Pharmacol Ther 2003; 18: 14150.
  • 6
    Parkman HP, Hasler WL, Fisher RS et al. Technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 124: 1592622.
  • 7
    Hoogerwerf WA, Pasricha PJ, Kalloo AN et al. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol 1999; 94: 102933.
    Direct Link:
  • 8
    Horowitz M, Su YC, Rayner CK et al. Gastroparesis: prevalence, clinical significance and treatment. Can J gastroenterol 2001; 15: 80513.
  • 9
    Gumaste V, Baum J. Treatment of gastroparesis: an update. Digestion 2008; 78: 1739.
  • 10
    Hasler W, Coleski R, Chey W et al. Difference in intragastric pH in diabetic vs. idiopathic gastroparesis: relation to degree of gastric retention. Am J Physiol Gastrointest Liver Physiol 2008; 294: GI38491.
  • 11
    Hasler WL. Gastroparesis – current concepts and considerations. Medscape J Med 2008; 10(1): 16.
  • 12
    Bytzer P, Talley NJ, Leemon M et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus. Arch Inter Med. 2001; 161: 198996.
  • 13
    Mearin F, Camilleri M, Malagelada J-R. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90: 191925.
  • 14
    Camilleri M, Malagelada J-R. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984; 14: 4207.
  • 15
    Feldman M, Corbett DB, Ramsey EJ et al. Abnormal gastric function in longstanding insulin-dependent diabetic patients. Gastroenterology 1979; 77: 127.
  • 16
    Merio R, Festa A, Bergmann H et al. Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose and glycemic control. Diabetes Care 1997; 20: 41923.
  • 17
    He CL, Soffer EE, Ferris CD et al. Loss of interstitial cells of Cajal and inhibitory innervations in insulin-dependent diabetes. Gastroenterology 2001; 121: 42734.
  • 18
    Iwasaki H, Najimura M, Osawa S et al. A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J Gastroenterol 2006; 41: 107687.
  • 19
    Forster J, Damjanov I, Lin Z, Sarosiek I, Wetzel P, McCallum RW. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 2005; 9: 1028.
  • 20
    Bityutskiy L, Soykan I, McCAllum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis, clinical characteristics and long-term outcome. Am J Gastroenterol 1997; 92: 15014.
  • 21
    McCallum R, Lin Z, Wetzel P, Sarosiek I, Forster J. Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis. Clin Gastroenterol Hepatol 2005; 3(1): 4954.
  • 22
    Mathias JR, Fernandez A, Sninsky CA et al. Nausea, vomiting, and abdominal pain after Roux-en-Y anastomosis: motility of the jejunal limb. Gastroenterology 1985; 88: 1017.
  • 23
    Frantzides CT, Carlson MA, Zografakis JG et al. Postoperative gastrointestinal complaints after laparoscopic Nissen fundoplication. JSLS 2006; 10: 3942.
  • 24
    Kozarek RA, Low DE, Raltz SL. Complications associated with laparoscopic anti-reflux surgery: one multispecialty clinic’s experience. Gastrointest Endosc 1997; 46: 52731.
  • 25
    Kraft RO, Fry WJ, DeWeese MS. Post-vagotomy gastric atony. Arch Surg 1964; 88: 86574.
  • 26
    Buckles DC, McCallum RW. Gastroparesis. Current Treatment Options in Gastroenterology 2004; 7: 13947.
  • 27
    McCallum RW, George SJ. Gastroparesis. Clin Perspect Gastroenterol 2001; 4: 12184.
  • 28
    Ganzini L, Casey DE, Hoffmen WL et al. The prevelance of metoclopramide-induced tardive dyskinesia and acute extrpyramidal movement disorders. Arch Intern Med 1993; 153: 146975.
  • 29
    Friedenberg FK, Palit A, Parkman HP, Nelson D. Randomized, placebo controlled trial of botulinum toxin A for the treatment of delayed gastric emptying. Gastroenterology 2007; 26: 12518.
  • 30
    Abell TL, Van Cutsem E, Abrahamsson H, Huizinga JD et al. Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion 2002; 66: 20412.
  • 31
    Abell T, McCallum RW, Hocking M et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003; 125(2): 4218.
  • 32
    McCallum RW, Pasricha PJ. Gastroparesis and gastric electrical stimulation: a useful option for gastroparesis. AGA Perspect 2006; 2(5).
  • 33
    Soffer E, Abell T, Lin Z et al. Review article: gastric electrical stimulation for gastroparesis – physiological foundations, technical aspects and clinical implications. Aliment Pharmacol Ther 2009; 30(7): 68194.
  • 34
    McCallum RW, Lin Z, Forster J, Roeser K, Hou Q, Sarosiek I. Gastric electrical stimulation improves outcome of patients with gastroparesis for up to 10 years. Clin Gastroenterol Hepatol 2011; 9: 3149.
  • 35
    Abell T, McCallum RW, Hocking M et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003; 125: 4218.
  • 36
    Namin F, Lin Z, Sarosiek I, McCallum RW. Gastric electrical stimulation: Who are the best Candidates and What are the results. Practical Gastroenterol, 2005; XXIX(9): 2847.
  • 37
    Forster J, Sarosiek I, Delcore R, Lin Z, Raju GS, McCallum RW. Gastric pacing is a new surgical treatment for gastroparesis. Am J Surgery 2001; 182: 67681.
  • 38
    Lin Z, Forster J, Sarosiek I, McCallum RW. Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation. Diabetes Care 2004; 27: 10716.
  • 39
    Lin Z, Forster J, Sarosiek I, McCallum RW. Effect of high-frequency electrical stimulation on gastric myoelectric activity in gastroparetic patients. Neurogastroenterol Motil 2004; 16: 20512.
  • 40
    McCallum RW, Chen JDZ, Lin Z et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology 1998; 114: 45661.
  • 41
    Nguyen LB, Parker S, Snape WJ. Is pyloroplasty a surgical option in the treatment of refractory gastroparesis? Gastroenterology 2007; 132: M1151. 42.
  • 42
    Abouezzi ZE, Melvin WS, Ellison EC, Schirmer WJ. Functional and symptomatic improvement in patients with diabetic gastroparesis following pyloroplasty (abstract). Gastroenterology 1998; 114: A1374. 43 (abstract).
  • 43
    McCallum RW, Lin Z, Wetzel P, Sarosiek I, Forster J. Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis. Clin Gastroenterol Hepatol 2005; 3: 4954.
  • 44
    McCallum RW, Soffer E, Pasricha J et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006; 18: 26383.
  • 45
    Reddymasu S, McCallum RW. Pharmacotherapy of gastroparesis. Expert Opin Pharmacother 2009; 10(3): 116.
  • 46
    US Food and Drug Administration. H990014–EnterraTM therapy system (formerly named gastric electrical stimulation (GES) system). Available at: Accessed March 31, 2000.
  • 47
    McCallum RW, Snape W, Brody F, Wo J, Parkman PL. Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study. Clin Gastroenterol Hepatol 2010; 8: 94754.
  • 48
    Sarosiek I, Forster J, Lin Z, Sarosiek J, Roeser K, McCallum R. The addition of pyloroplasty is a new surgical approach that enhances the clinical outcome to gastric electrical stimulation (Enterra) in patients with post-vagotomy gastroparesis compared to diabetic/idiopathic gastroparesis. Abstract AGA 2008. Gastroenterology 2008; 134(Suppl): A550 (abstract).
  • 49
    Hibbard ML, Dunst CM, Swanstrom LL. Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptoms improvement. J Gastrointest Surg 2011; 15: 15139.
  • 50
    Reddymasu S, Shailender S, Sankula R, Lavenbarg T, McCallum RW. Endoscopic pyloric injection of Botulinum Toxin A for the treatment of postvagotomy gastroparesis. Am J Med Sci 2009; 337: 161–4.
  • 51
    Walia R, Bremmer RM, Huang JL, Varsch KE, Smith MA. Gastroparesis is common following Lung transplantation and may be ameliorated by Botox injection of the pylorus. Ann Mtg Int Soc Heart Lung Transplant 2011, Meeting proceedings, p. 129, abstract.
  • 52
    McCallum RW, Dusing RW, Sarosiek I, Cocjin J, Forster J, Lin Z. Mechanisms of symptomatic improvement after gastric electrical stimulation in gastroparetic patients. Neurogastroenterol Motil 2010; 22: 1617.